Related references
Note: Only part of the references are listed.Menopause in women with multiple sclerosis: A systematic review
Vasilios Karageorgiou et al.
MATURITAS (2020)
Impact of sex hormones on immune function and multiple sclerosis development
Maria C. Ysrraelit et al.
IMMUNOLOGY (2019)
Impact of natural menopause on multiple sclerosis: a multicentre study
Damiano Baroncini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Prevalence and Psychopathological Determinants of Sexual Dysfunction and Related Distress in Women With and Without Multiple Sclerosis
Giulia Gava et al.
JOURNAL OF SEXUAL MEDICINE (2019)
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors
Maria Pia Amato et al.
PLOS ONE (2019)
Female Sexual Dysfunction Among Greek Women With Multiple Sclerosis: Correlations With Organic and Psychological Factors
Charalampos Konstantinidis et al.
SEXUAL MEDICINE (2019)
Complementary and Alternative Medicine for Menopause
Alisa Johnson et al.
JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE (2019)
Ovarian aging is associated with gray matter volume and disability in women with MS
Jennifer S. Graves et al.
NEUROLOGY (2018)
The influence and impact of ageing and immunosenescence (ISC) on adaptive immunity during multiple sclerosis (MS) and the animal counterpart experimental autoimmune encephalomyelitis (EAE)
Christopher Bolton et al.
AGEING RESEARCH REVIEWS (2018)
Caring for Women with Multiple Sclerosis Across the Lifespan
Kelsey Rankin et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients
Elizabeth A. Mills et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial
Kejal Kantarci et al.
NEUROLOGY (2018)
Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women
Nils Koch-Henriksen et al.
NEUROLOGY (2018)
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients
Elizabeth A. Mills et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Multiple Sclerosis Drug Fingolimod Induces Thrombotic Microangiopathy in Deoxycorticosterone Acetate/Salt Hypertension
Yoshitaka Iwazu et al.
HYPERTENSION (2018)
The Influence of Menopause in Multiple Sclerosis Course: A Longitudinal Cohort Study
Filipa Ladeira et al.
EUROPEAN NEUROLOGY (2018)
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial
Laura De Giglio et al.
CNS DRUGS (2017)
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
Luis Ruano et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy
Alice Laroni et al.
NEUROLOGICAL SCIENCES (2017)
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
Luis Ruano et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis
Rosa E. Boeschoten et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Preventing urinary tract infections after menopause without antibiotics
Marta Caretto et al.
MATURITAS (2017)
The 2017 hormone therapy position statement of The North American Menopause Society
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Cognitive impairment in multiple sclerosis - a review of current knowledge and recent research
Tomasz Grzegorski et al.
REVIEWS IN THE NEUROSCIENCES (2017)
Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension
Anja Meissner et al.
CARDIOVASCULAR RESEARCH (2017)
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort
Riley Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort
Riley Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
Cecilia Smith Simonsen et al.
BMC NEUROLOGY (2016)
The impact of micronized progesterone on the endometrium: a systematic review
P. Stute et al.
CLIMACTERIC (2016)
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
Rhonda R. Voskuhl et al.
LANCET NEUROLOGY (2016)
Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review
Martine Depmann et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2016)
Aging and multiple sclerosis
Shaik Ahmed Sanai et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis
Riley Bove et al.
NEUROLOGY (2016)
Women's Issues in Multiple Sclerosis
Riley Bove
SEMINARS IN NEUROLOGY (2016)
Aging and multiple sclerosis
Shaik Ahmed Sanai et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Poor sleep quality in patients with multiple sclerosis: gender differences
Marianna Vitkova et al.
BRAIN AND BEHAVIOR (2016)
Bone health in patients with multiple sclerosis relapses
Olwen Murphy et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Women's experiences of menopause in an online MS cohort: A case series
R. Bove et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Differing trends in the incidence of vascular comorbidity in MS and the general population
Ruth Ann Marrie et al.
NEUROLOGY-CLINICAL PRACTICE (2016)
Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis
Serap Zengin Karahan et al.
MULTIPLE SCLEROSIS INTERNATIONAL (2016)
How sex and age affect immune responses, susceptibility to infections, and response to vaccination
Carmen Giefing-Kroell et al.
AGING CELL (2015)
The urogenital system and the menopause
J. Calleja-Agius et al.
CLIMACTERIC (2015)
Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study
Carey E. Gleason et al.
PLOS MEDICINE (2015)
Patients report worse MS symptoms after menopause: Findings from an online cohort
R. Bove et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Serum anti-Mullerian hormone levels in reproductive-age women with relapsing-remitting multiple sclerosis
Jan Thoene et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Oral contraceptives combined with interferon beta in multiple sclerosis
Carlo Pozzilli et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Risks of Endometrial Cancer Associated With Different Hormone Replacement Therapies in the E3N Cohort, 1992-2008
Agnes Fournier et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis
Giulia Gava et al.
FERTILITY AND STERILITY (2014)
Menopause in multiple sclerosis: therapeutic considerations
Riley Bove et al.
JOURNAL OF NEUROLOGY (2014)
The link between multiple sclerosis and depression
Anthony Feinstein et al.
NATURE REVIEWS NEUROLOGY (2014)
Probing the impact of sex steroids and menopause-related sex steroid deprivation on modulation of immune senescence
Nikolaos Vrachnis et al.
MATURITAS (2014)
Low-Dose Estradiol and the Serotonin-Norepinephrine Reuptake Inhibitor Venlafaxine for Vasomotor Symptoms A Randomized Clinical Trial
Hadine Joffe et al.
JAMA INTERNAL MEDICINE (2014)
Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex
Mahsa Ghajarzadeh et al.
ACTA NEUROLOGICA BELGICA (2013)
Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials
JoAnn E. Manson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
Melih Tutuncu et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis: A Systematic Review and Turkish Consensus Report
Bulent Cetinel et al.
NEUROUROLOGY AND URODYNAMICS (2013)
Cognitive and neuropsychiatric disease manifestations in MS
A. Feinstein et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2013)
Pap, Mammography, and Clinical Breast Examination Screening Among Women with Disabilities: A Systematic Review
Elena M. Andresen et al.
WOMENS HEALTH ISSUES (2013)
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service
Mitchell T. Wallin et al.
BRAIN (2012)
Glucocorticoid-Induced Osteoporosis and Osteonecrosis
Robert S. Weinstein
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis
M. B. D'hooghe et al.
JOURNAL OF NEUROLOGY (2012)
Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis
Allan J. MacKenzie-Graham et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis
Armando Sena et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Effect of gender on late-onset multiple sclerosis
Riley M. Bove et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Oophorectomy, menopause, estrogen treatment, and cognitive aging: Clinical evidence for a window of opportunity
Walter A. Rocca et al.
BRAIN RESEARCH (2011)
Non-Hormonal Treatment Strategies for Vasomotor Symptoms A Critical Review
Elise Hall et al.
DRUGS (2011)
Multiple sclerosis and depression
Anthony Feinstein
MULTIPLE SCLEROSIS JOURNAL (2011)
Sleep During the Perimenopause: A SWAN Story
Howard M. Kravitz et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2011)
A Validated Model of Serum Anti-Mullerian Hormone from Conception to Menopause
Thomas W. Kelsey et al.
PLOS ONE (2011)
Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis
Per Holmqvist et al.
FERTILITY AND STERILITY (2010)
Osteoporosis in multiple sclerosis
Andrew P. Hearn et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
R. A. Marrie et al.
NEUROLOGY (2010)
Management of osteoporosis in postmenopausal women
&NA;
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety
David F. Archer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause
David F. Archer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Estrogen treatment in multiple sclerosis
Stefan M. Gold et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Comorbidity delays diagnosis and increases disability at diagnosis in MS
R. A. Marrie et al.
NEUROLOGY (2009)
Prevalence of 'poor sleep' among patients with multiple sclerosis: An independent predictor of mental and physical status
G. Merlino et al.
SLEEP MEDICINE (2009)
Cognitive impairment in multiple sclerosis
Nancy D. Chiaravalloti et al.
LANCET NEUROLOGY (2008)
Prevalence of sleep problems in individuals with multiple sclerosis
A. M. Bamer et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Psychiatric issues in multiple sclerosis
Lydia A. Chwastiak et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)
The neurogenic bladder in Multiple Sclerosis multiple sclerosis:: review of the literature and proposal of management guidelines
Marianne de Seze et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
Stephen L. Hauser et al.
NEURON (2006)
Monitoring reproductive aging in a 5-year prospective study:: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age
RJ Ferrell et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2005)
Breast cancer risk in the WHI study: The problem of obesity
H Kuhl
MATURITAS (2005)
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women - The Women's Health Initiative Memory Study: A randomized controlled trial
SA Shumaker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Bone status in multiple sclerosis: beyond corticosteroids
S Tuzun et al.
MULTIPLE SCLEROSIS (2003)
Menopause, local biologies, and cultures of aging
M Lock et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2001)
Factors associated with age at natural menopause in a multiethnic sample of midlife women
EB Gold et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups
NE Avis et al.
SOCIAL SCIENCE & MEDICINE (2001)
Share Paper
